Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
RedHill Biopharma
RedHill Biopharma
(RDHL)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Aemcolo
Rifamycin
2018-11-16
2025
—
Talicia
Amoxicillin
,
Omeprazole
,
Rifabutin
2019-11-01
2026-2042
Urinary tract infections
,
Sinusitis
,
Otitis media
,
Bacterial infections
,
Bacterial skin diseases
,
Soft tissue infections
,
Chlamydia infections
,
Helicobacter infections
,
Duodenal ulcer
,
Streptococcal infections
,
Lyme disease
,
Listeriosis
,
Human bites
,
Actinomycosis
,
Staphylococcal infections
,
Haemophilus infections
,
Nontuberculous mycobacterium infections
,
Gastroesophageal reflux
,
Infectious skin diseases
,
Mycoplasma pneumonia
,
Bronchitis
,
Stomach ulcer
,
Tonsillitis
,
Zollinger-ellison syndrome
,
Esophagitis
,
Protozoan infections
,
Pulmonary tuberculosis
,
Mycobacterium avium-intracellulare infection
,
Heartburn
,
Mycobacterium infections
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Amoxicillin
infections
Omeprazole
inflammatory bowel diseases
,
intestinal diseases
,
rheumatoid arthritis
,
arthritis
,
osteoarthritis
Rifabutin
healthy volunteers/patients
,
hiv infections
,
nontuberculous mycobacterium infections
,
mycoses
,
infections
,
communicable diseases
,
mycobacterium infections
,
mycobacterium avium-intracellulare infection
,
mycobacterium avium complex
,
lung diseases
,
tuberculosis
Rifamycin
diarrhea
,
dysentery
,
lung diseases
,
mycobacterium avium complex
,
bronchiectasis
,
mycobacterium avium-intracellulare infection
,
mycobacterium infections
,
crohn disease
,
paratuberculosis
,
infections
,
dyspepsia
Interferon beta
sclerosis
,
relapsing-remitting multiple sclerosis
,
multiple sclerosis
,
anemia
,
hepatitis c
,
chronic hepatitis c
,
infections
,
hiv infections
,
acquired immunodeficiency syndrome
,
cytomegalovirus retinitis
,
retinitis
Benzocaine
myoclonic epilepsies
,
syndrome
Benzimidazole
healthy volunteers/patients
,
infections
,
communicable diseases
,
helicobacter infections
,
esophagitis
Opaganib
pancreatic neoplasms
,
neoplasms
,
cholangiocarcinoma
,
klatskin tumor
,
coronavirus infections
,
multiple myeloma
,
plasma cell neoplasms
,
sarcoma
,
lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
kaposi sarcoma
,
pneumonia
,
covid-19
Serine
colorectal neoplasms
,
neoplasms
,
squamous cell carcinoma of head and neck
,
biliary tract neoplasms
Aspartame
beta-thalassemia
,
thalassemia
,
iron overload
,
newborn respiratory distress syndrome
,
asthma
Nepidermin
anemia
,
deficiency diseases
,
chronic renal insufficiency
,
kidney diseases
,
neoplasms
,
inflammatory bowel diseases
,
intestinal diseases
,
iron deficiencies
,
iron-deficiency anemia
,
heart failure
,
left ventricular dysfunction
Upamostat
sars-cov-2
,
covid-19
Lactams
healthy volunteers/patients
,
melanoma
,
prostatic neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
sarcoma
,
recurrence
,
non-hodgkin lymphoma
,
neoplasms
,
neoplasm metastasis
,
endometrial neoplasms
,
left ventricular dysfunction
,
salivary gland neoplasms
,
urologic neoplasms
,
lung neoplasms
,
urinary bladder neoplasms
,
brain neoplasms
,
breast neoplasms
,
pregnancy
Bekinda
irritable bowel syndrome
,
diarrhea
,
syndrome
,
vomiting
,
gastritis
,
gastroenteritis
Hidroxicloroquina
prostatic neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use